Cargando…
Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats
SIMPLE SUMMARY: Serum Amyloid A (SAA) is one of the most sensitive tests to detect inflammation in cats. In this study, two point-of-care assays for serum amyloid A measurements in cats were analytically evaluated. The two assays were accurate and showed significant correlations with an automated as...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469286/ https://www.ncbi.nlm.nih.gov/pubmed/34573484 http://dx.doi.org/10.3390/ani11092518 |
_version_ | 1784573892067590144 |
---|---|
author | Escribano, Damián Bustillo, Alba Ortín Marín, Luis Pardo Rabasco, Andrea Navarro Herrera, Pablo Ruiz Cerón, Jose J. Tvarijonaviciute, Asta |
author_facet | Escribano, Damián Bustillo, Alba Ortín Marín, Luis Pardo Rabasco, Andrea Navarro Herrera, Pablo Ruiz Cerón, Jose J. Tvarijonaviciute, Asta |
author_sort | Escribano, Damián |
collection | PubMed |
description | SIMPLE SUMMARY: Serum Amyloid A (SAA) is one of the most sensitive tests to detect inflammation in cats. In this study, two point-of-care assays for serum amyloid A measurements in cats were analytically evaluated. The two assays were accurate and showed significant correlations with an automated assay previously validated in cats, although one of them did not show an optimal precision. Both assays were able to detect higher SAA concentrations in cats with inflammatory diseases than in cats without inflammatory diseases. In conclusion, this manuscript provides data about the possible application of two point-of-care assays for the measurement of SAA concentration in cats. ABSTRACT: Serum Amyloid A (SAA) is one of the most sensitive tests to detect inflammation in cats. In this study, two point-of-care assays for SAA measurements in cats (FUJI DRI-CHEM IMMUNO AU CARTRIDGE vf-SAA (method A), and CUBE-VET analyser (Method B), were analytically evaluated. Regarding the imprecision precision only the method A showed intra-assay and inter-assay CV < 10% at all concentrations. Both assays showed linearity with r close to 1 and the recovery were in the range of 81–112% for assay A and 85–125% for assay B and the limit of detection were 3.75 and 0.5 mg/dL for method A and B, respectively. A previously validated method for SAA quantification SAATIA; LZ-SAA (method C) was used as gold-standard to evaluate the accuracy of the assays. Significant correlations (p < 0.0001) were found between assays A and C (r = 0.94) and B and C (r = 0.91). In addition, an overlap performance test was made using serum samples from cats with non-inflammatory and cats with inflammatory. Both assays showed higher median SAA concentrations in cats with inflammatory diseases than in cats without inflammatory diseases (p < 0.0001). In conclusion, this manuscript provides data about the possible application of two point-of-care assays for the measurement of SAA concentration in cats. |
format | Online Article Text |
id | pubmed-8469286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84692862021-09-27 Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats Escribano, Damián Bustillo, Alba Ortín Marín, Luis Pardo Rabasco, Andrea Navarro Herrera, Pablo Ruiz Cerón, Jose J. Tvarijonaviciute, Asta Animals (Basel) Communication SIMPLE SUMMARY: Serum Amyloid A (SAA) is one of the most sensitive tests to detect inflammation in cats. In this study, two point-of-care assays for serum amyloid A measurements in cats were analytically evaluated. The two assays were accurate and showed significant correlations with an automated assay previously validated in cats, although one of them did not show an optimal precision. Both assays were able to detect higher SAA concentrations in cats with inflammatory diseases than in cats without inflammatory diseases. In conclusion, this manuscript provides data about the possible application of two point-of-care assays for the measurement of SAA concentration in cats. ABSTRACT: Serum Amyloid A (SAA) is one of the most sensitive tests to detect inflammation in cats. In this study, two point-of-care assays for SAA measurements in cats (FUJI DRI-CHEM IMMUNO AU CARTRIDGE vf-SAA (method A), and CUBE-VET analyser (Method B), were analytically evaluated. Regarding the imprecision precision only the method A showed intra-assay and inter-assay CV < 10% at all concentrations. Both assays showed linearity with r close to 1 and the recovery were in the range of 81–112% for assay A and 85–125% for assay B and the limit of detection were 3.75 and 0.5 mg/dL for method A and B, respectively. A previously validated method for SAA quantification SAATIA; LZ-SAA (method C) was used as gold-standard to evaluate the accuracy of the assays. Significant correlations (p < 0.0001) were found between assays A and C (r = 0.94) and B and C (r = 0.91). In addition, an overlap performance test was made using serum samples from cats with non-inflammatory and cats with inflammatory. Both assays showed higher median SAA concentrations in cats with inflammatory diseases than in cats without inflammatory diseases (p < 0.0001). In conclusion, this manuscript provides data about the possible application of two point-of-care assays for the measurement of SAA concentration in cats. MDPI 2021-08-27 /pmc/articles/PMC8469286/ /pubmed/34573484 http://dx.doi.org/10.3390/ani11092518 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Escribano, Damián Bustillo, Alba Ortín Marín, Luis Pardo Rabasco, Andrea Navarro Herrera, Pablo Ruiz Cerón, Jose J. Tvarijonaviciute, Asta Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats |
title | Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats |
title_full | Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats |
title_fullStr | Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats |
title_full_unstemmed | Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats |
title_short | Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats |
title_sort | analytical validation of two point-of-care assays for serum amyloid a measurements in cats |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469286/ https://www.ncbi.nlm.nih.gov/pubmed/34573484 http://dx.doi.org/10.3390/ani11092518 |
work_keys_str_mv | AT escribanodamian analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats AT bustilloalbaortin analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats AT marinluispardo analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats AT rabascoandreanavarro analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats AT herrerapabloruiz analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats AT ceronjosej analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats AT tvarijonaviciuteasta analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats |